Ten years ago, the famous Ugandan dancer, musician, DJ and radio reporter Moses ‘Supercharger’ Nsubuga traveled back to his home town in Uganda to die. He was very sick although he was taking his HIV drugs. Moses had developed HIV drug resistance. To save costs...
Viral suppression is the cornerstone of success in long-term HIV treatment. The World Health Organization commissioned us to systematically review the scientific literature on HIV treatment outcomes. We focused on the viral loads of adults on first-line antiretroviral therapy for HIV-1 in low- and middle-income...
With the progressive scale-up of antiretroviral therapy in Africa, pre-treatment drug resistance is increasing. People who have never been on treatment are found to harbour drug resistant HIV even before they start first-line antiretroviral therapy. In the PanAfrican Studies to Evaluate Resistance (PASER) cohort, a...
Antiretroviral drugs are proven to prevent people from acquiring HIV. The effectiveness of this pre-exposure prophylaxis (PrEP) in clinical trials now is being put to the test in real world settings, with excellent results presented at the recent AIDS 2015 conference in Vancouver. This paper...
Read this article about Joep Lange and the launch of the Joep Lange Institute: http://news.sciencemag.org/health/2015/07/new-institute-carry-work-hiv-pioneer-and-mh17-victim-joep-lange ...
Watch here the Nieuwsuur item of 15-7-2015 with announcement of the Joep Lange Institute. ...